Clinical Trial

A Phase 1 Study of KHN707 Tablets in Healthy Participants

Name: A Phase 1 Study of KHN707 Tablets in Healthy Participants — clinical trial record (NCT07557537)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-center, randomized, double-blind, placebo-controlled study . The objective is to evaluate the safety , tolerability and PK profile of KHN707 tablets in Chinese healthy participants.

Trial Details

NCT Number	NCT07557537
Lead Sponsor	Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Conditions	Healthy Adult Participants
Enrollment	38 participants
Start Date	2026-05
Primary Completion	2026-10 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2026-04-29